Natalia Rosso

Dr. Natalia Rosso

Fondazione Italiana Fegato, Trieste, Friuli-Venezia Giulia, Italy
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2018 in Liver International
Verified
Journal Article
Closed access
PDF file
AAAna Ruth Araújo
Ana Ruth Araújo
NRNatalia Rosso
Natalia Rosso
GBGiorgio Bedogni
Giorgio Bedogni
CTClaudio Tiribelli
Claudio Tiribelli
SBSTEFANO Bellentani
STEFANO Bellentani

1 March 2012 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
NCNorberto Chavez-Tapia
Norberto Chavez-Tapia
NRNatalia Rosso
Natalia Rosso
CTClaudio Tiribelli
Claudio Tiribelli
In vitro exposure of liver cells to high concentrations of free fatty acids (FFA) results in fat overload which promotes inflammatory and fibrogenic response similar to those observed in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). Since the mechanisms of this event have not been fully characterized, we aimed to analyze the fibrogenic stimuli in a new in vitro model of NASH.

1 January 2007 in Molecular Medicine
Verified
Journal Article
Open access
VMVittorio Di Maso
Vittorio Di Maso
CAClaudio Avellini
Claudio Avellini
LClory saveria croce'
lory saveria croce'
NRNatalia Rosso
Natalia Rosso
FQFranco Quadrifoglio
Franco Quadrifoglio
CTClaudio Tiribelli
Claudio Tiribelli
APE1/Ref-1, normally localized in the nucleus, is a regulator of the cellular response to oxidative stress. Cytoplasmic localization has been observed in several tumors and correlates with a poor prognosis. Because no data are available on liver tumors, we investigated APE1/Ref-1 subcellular localization and its correlation with survival in 47 consecutive patients undergoing hepatocellular carcinoma (HCC) resection. APE1/Ref-1 expression was determined by immunohistochemistry in HCC and surrounding liver cirrhosis (SLC) and compared with normal liver tissue. Survival probability was evaluated using Kaplan-Meier curves (log-rank test) and Cox regression. Cytoplasmic expression of APE1/Ref-1 was significantly higher in HCC than in SLC (P = 0.00001); normal liver showed only nuclear reactivity. Patients with poorly differentiated HCC showed a cytoplasmic expression three times higher than those with well-differentiated HCC (P = 0.03). Cytoplasmic localization was associated with a median survival time shorter than those with negative cytoplasmic reactivity (0.44 compared with 1.64 years, P = 0.003), and multivariable analysis confirmed that cytoplasmic APE1/Ref-1 localization is a predictor of survival. Cytoplasmic expression of APE1/Ref-1 is increased in HCC and is associated with a lower degree of differentiation and a shorter survival time, pointing to the use of the cytoplasmic localization of APE1/Ref-1 as a prognostic marker for HCC.

1 November 2017 in Journal of Hepatology
Verified
Journal Article
Closed access
VMVeronica Marin
Veronica Marin
KPKyle Poulsen
Kyle Poulsen
GOGemma Odena
Gemma Odena
MMMegan R. McMullen
Megan R. McMullen
JAJose Altamirano
Jose Altamirano
LNLaura E Nagy
Laura E Nagy

1 March 2011 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
NCNorberto Chavez-Tapia
Norberto Chavez-Tapia
NRNatalia Rosso
Natalia Rosso
CTClaudio Tiribelli
Claudio Tiribelli
Non-alcoholic fatty liver disease is regarded as the hepatic manifestation of metabolic syndrome and is an important and common cause of chronic liver disease with a potential to develop end-stage liver disease. While important advances in the pathophysiology have been achieved using genetically modified and diet-induced animal models, in-vitro models have been only recently proposed. These models include primary culture and immortalized cell lines. Here we critically review the characteristics of the in vitro models described, the advantages and limitations of the in vitro approach, and the results derived.